- 1Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa
- 2Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, United States
- 3Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States
- 4Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
- 5Laboratório de Pesquisa Clínica e Translacional, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil
- 6Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa
- 7Global Division, The Aurum Institute, Johannesburg, South Africa
- 8Department of Infection and Immunity, University College of London, London, United Kingdom
- 9Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States
- 10Centers for AIDS Research and Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL, United States
By Cumming BM, Addicott KW, Maruri F, Pillay V, Asmal R, Moodley S, Barreto-Durate B, Araújo-Pereira M, Mazibuko M, Mhlane Z, Mbatha N, Khan K, Makhari S, Karim F, Peetluk L, Pym AS, Moosa MYS, van der Heijden YF, Sterling TS, Andrade BB, Leslie A and Steyn AJC (2024) Front. Immunol. 15:1465448. doi: 10.3389/fimmu.2024.1465448
In the published article, there was an error in the article title. Instead of “Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment”, it should be “Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: tuberculosis, bioenergetic metabolism, lymphocytes, monocytes, TB treatment, cytokines, Seahorse XF96
Citation: Cumming BM, Addicott KW, Maruri F, Pillay V, Asmal R, Moodley S, Barreto-Durate B, Araújo-Pereira M, Mazibuko M, Mhlane Z, Mbatha N, Khan K, Makhari S, Karim F, Peetluk L, Pym AS, Moosa MYS, van der Heijden YF, Sterling TS, Andrade BB, Leslie A and Steyn AJC (2025) Corrigendum: Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients. Front. Immunol. 16:1557327. doi: 10.3389/fimmu.2025.1557327
Received: 08 January 2025; Accepted: 09 January 2025;
Published: 30 January 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Cumming, Addicott, Maruri, Pillay, Asmal, Moodley, Barreto-Durate, Araújo-Pereira, Mazibuko, Mhlane, Mbatha, Khan, Makhari, Karim, Peetluk, Pym, Moosa, van der Heijden, Sterling, Andrade, Leslie and Steyn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Adrie J. C. Steyn, YXN0ZXluQHVhYi5lZHU=; YWRyaWUuc3RleW5AYWhyaS5vcmc=